KDR c.889G>T ;(p.V297L)

Variant ID: 4-55979558-C-A

NM_002253.2(KDR):c.889G>T;(p.V297L)

This variant was identified in 2 publications

View GRCh38 version.




Publications:


The Influence of KDR Genetic Variation on the Efficacy and Safety of Patients With Advanced NSCLC Receiving First-Line Bevacizumab Plus Chemotherapy Regimen.

Technology In Cancer Research & Treatment
Geng, Nan N; Su, Jingwei J; Liu, Zhikun Z; Ding, Cuimin C; Xie, Shaonan S; Hu, Wenxia W
Publication Date: 2021

Variant appearance in text: KDR: V297L; rs2305948
PubMed Link: 34060368
Variant Present in the following documents:
  • Main text
  • 10.1177_15330338211019433.pdf
View BVdb publication page



Functional PTGS2 polymorphism-based models as novel predictive markers in metastatic renal cell carcinoma patients receiving first-line sunitinib.

Scientific Reports
Cebrián, Arancha A; Gómez Del Pulgar, Teresa T; Méndez-Vidal, María José MJ; Gonzálvez, María Luisa ML; Lainez, Nuria N; Castellano, Daniel D; García-Carbonero, Iciar I; Esteban, Emilio E; Sáez, Maria Isabel MI; Villatoro, Rosa R; Suárez, Cristina C; Carrato, Alfredo A; Munárriz-Ferrándiz, Javier J; Basterrechea, Laura L; García-Alonso, Mirta M; González-Larriba, José Luis JL; Perez-Valderrama, Begoña B; Cruz-Jurado, Josefina J; González Del Alba, Aránzazu A; Moreno, Fernando F; Reynés, Gaspar G; Rodríguez-Remírez, María M; Boni, Valentina V; Mahillo-Fernández, Ignacio I; Martin, Yolanda Y; Viqueira, Andrea A; García-Foncillas, Jesús J
Publication Date: 2017-01-24

Variant appearance in text: KDR: V297L; rs2305948
PubMed Link: 28117391
Variant Present in the following documents:
  • Main text
  • srep41371.pdf
View BVdb publication page